CN102698094B - Medicament for treating female depression - Google Patents
Medicament for treating female depression Download PDFInfo
- Publication number
- CN102698094B CN102698094B CN 201210199464 CN201210199464A CN102698094B CN 102698094 B CN102698094 B CN 102698094B CN 201210199464 CN201210199464 CN 201210199464 CN 201210199464 A CN201210199464 A CN 201210199464A CN 102698094 B CN102698094 B CN 102698094B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- radix
- root
- treating female
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 5
- 241001071795 Gentiana Species 0.000 claims abstract description 3
- 208000020401 Depressive disease Diseases 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 4
- 241000605447 Anemarrhena Species 0.000 claims description 2
- 240000001972 Gardenia jasminoides Species 0.000 claims description 2
- 241000208966 Polygala Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 241000208682 Liquidambar Species 0.000 abstract 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 description 5
- 230000008451 emotion Effects 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 230000010354 integration Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000000994 depressogenic effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 208000020016 psychiatric disease Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010042458 Suicidal ideation Diseases 0.000 description 2
- -1 absorption carrier Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating female depression. The medicament is prepared from the following substances by weight: spina date seed, costus root, thinleaf milkwort root-bark, gentian, tall gastrodia tuber, baikal skullcap root, common clubmoss herb, dwarf lilyturf root, common anemarrhena, Chinese angelica, beautiful sweetgum fruit, liquoric root, oriental waterplantain rhizome, white mulberry boot-bark, fructus gardenia and Chinese magnoliavine fruit. All the components of the medicament for treating female depression are natural materials, so that the medicament is high in safety, has an exact curative effect and is suitable for clinical large-scale popularization.
Description
Technical field
The present invention relates to the psychiatric nursing field, relate in particular to a kind of medicament for the treatment of Depression in women.
Background technology
Depression in women is the common mental disorder of women, mainly shows as emotion melancholy, anxiety, insomnia, and irritability, desperate helpless, things is lost interest, degradation under the self-value to external world.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of Depression in women.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of Depression in women, it is to be made by following materials by weight: Semen Ziziphi Spinosae 3-5 part, Radix Aucklandiae 1-3 part, Radix Polygalae 1-3 part, Radix Gentianae 2-5 part, Rhizoma Gastrodiae 0.1-0.5 part, Radix Scutellariae 1-3 part, Herba Lycopodii 2-5 part, Radix Ophiopogonis 1-3 part, Rhizoma Anemarrhenae 3-5 part, Radix Angelicae Sinensis 3-5 part, Fructus Liquidambaris 1-3 part, Radix Glycyrrhizae 5-8 part, Rhizoma Alismatis 1-3 part, Cortex Mori 1-3 part, Fructus Gardeniae 3-5 part and Fructus Schisandrae Chinensis 1-3 part.
Preferably, the medicament for the treatment of Depression in women of the present invention is to be made by following materials by weight: 1 part of 3 parts of Semen Ziziphi Spinosaes, 2 parts of the Radix Aucklandiae, 3 parts of Radix Polygalaes, 2 parts of Radix Gentianaes, 0.3 part in Rhizoma Gastrodiae, 2 parts of Radix Scutellariaes, 4 parts of Herba Lycopodiis, 2 parts of Radix Ophiopogonis, 4 parts of the Rhizoma Anemarrhenaes, 3 parts of Radix Angelicae Sinensis, 2 parts of Fructus Liquidambaris, 6 parts in Radix Glycyrrhizae, 2 parts of Rhizoma Alismatis, 2 parts of Cortex Mori, 4 parts of Fructus Gardeniaes and Fructus Schisandrae Chinensis.
Preferably, medicament of the present invention can be tablet, dispersible tablet, capsule or ointment.Can adopt method well known to those skilled in the art to carry out medicaments preparation.As required, can add various pharmaceutically acceptable carriers.Described carrier comprises diluent, excipient, filler, binding agent, wetting agent, disintegrating agent, absorption enhancer, surfactant, absorption carrier, lubricant of pharmaceutical field routine etc.Medicament of the present invention in the preparation, selectable filler has: starch, Icing Sugar, calcium phosphate, dextrin, microcrystalline Cellulose, lactose, pregelatinized Starch, mannitol etc.; Selectable binding agent has: sodium carboxymethyl cellulose, PVP-K30, hydroxypropyl cellulose, starch slurry, methylcellulose, ethyl cellulose, hydroxypropyl emthylcellulose, gelling starch etc.; Selectable disintegrating agent has: dried starch, polyvinylpolypyrrolidone, cross-linking sodium carboxymethyl cellulose, carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose etc.; Selectable lubricant has: magnesium stearate, Pulvis Talci, sodium lauryl sulphate, micropowder silica gel etc.
Whole compositions of the medicament for the treatment of Depression in women of the present invention all are natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further specify the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
Embodiment decoction of the present invention
Take by weighing Semen Ziziphi Spinosae 30 gram, the Radix Aucklandiae 20 grams, Radix Polygalae 30 grams, Radix Gentianae 20 grams, Rhizoma Gastrodiae 3 grams, Radix Scutellariae 20 grams, Herba Lycopodii 40 grams, Radix Ophiopogonis 20 gram, the Rhizoma Anemarrhenae 40 grams, Radix Angelicae Sinensis 30 grams, Fructus Liquidambaris 20 grams, Radix Glycyrrhizae 60 grams, Rhizoma Alismatis 20 grams, Cortex Mori 20 grams, Fructus Gardeniae 40 grams and Fructus Schisandrae Chinensis 10 grams, add 800 ml waters, heating is 3 hours under the condition that refluxes, filter, filtrate is cooled off namely.
Experimental example
60 routine female patients, age 32-50 year, the course of disease is the longest 7 years, the shortest 6 months, depressed 40 examples of mild or moderate, depressed 17 examples of moderate, severe depression 3 examples.It is hollow or desperate to show as life, and sad melancholy is kind cries, and depressed, interest goes down, palpitation and insomnia, susceptible to lose temper due to restlessness, and inadequate sexual desire, self-value descends until suicidal tendency etc. is arranged.
Diagnostic criteria reference up-to-date " Chinese mental disorder classification and diagnostic criteria " (Chen Yanfang. Chinese mental disorder classification and diagnostic criteria [M]. the 3rd edition. Jinan: Shandong science tech publishing house, 2001.), be standards of grading according to Hamilton Hamilton depressive scale (HAMD) (17 versions).Get rid of previously be mentally ill medical history and family's psychiatric history, because disturbance of consciousness, aphasia, dementia etc. influence language understanding and emotional expression, and have the suicidal tendency should not be with Drug therapy person.
Use the decoction of preparation among the embodiment 1 to treat for above-mentioned patient, every day twice, each 30 milliliters, treated continuously 40 days.
Criterion of therapeutical effect
According to 17 versions of HAMD curative effect standards of grading and " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease diagnosis criterion of therapeutical effect [M]. Nanjing: publishing house of Nanjing University, 1994.).Produce effects: integration was down to 7 fens, transference cure or obviously improvement, and emotion is normal.Effectively: integration is down to the 8-10 branch, and partial symptoms is improved, and emotion is basicly stable.Invalid: integration is more than 18 minutes, and the symptom emotion does not have improvement.
Through treatment, find that whole patients' integration was down to 7 fens, 42 routine patient's transference cures wherein, 18 routine patient's symptoms are obviously improved, and all patients' emotion is normal.Through judging, all meet the criterion of therapeutical effect of produce effects.
Claims (1)
1. medicament for the treatment of Depression in women, it is characterized in that it is to be made by following materials by weight: 1 part of 3 parts of Semen Ziziphi Spinosaes, 2 parts of the Radix Aucklandiae, 3 parts of Radix Polygalaes, 2 parts of Radix Gentianaes, 0.3 part in Rhizoma Gastrodiae, 2 parts of Radix Scutellariaes, 4 parts of Herba Lycopodiis, 2 parts of Radix Ophiopogonis, 4 parts of the Rhizoma Anemarrhenaes, 3 parts of Radix Angelicae Sinensis, 2 parts of Fructus Liquidambaris, 6 parts in Radix Glycyrrhizae, 2 parts of Rhizoma Alismatis, 2 parts of Cortex Mori, 4 parts of Fructus Gardeniaes and Fructus Schisandrae Chinensis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210199464 CN102698094B (en) | 2012-06-18 | 2012-06-18 | Medicament for treating female depression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210199464 CN102698094B (en) | 2012-06-18 | 2012-06-18 | Medicament for treating female depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102698094A CN102698094A (en) | 2012-10-03 |
| CN102698094B true CN102698094B (en) | 2013-07-10 |
Family
ID=46891341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210199464 Active CN102698094B (en) | 2012-06-18 | 2012-06-18 | Medicament for treating female depression |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102698094B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126024A (en) * | 2015-09-09 | 2015-12-09 | 孔令刚 | Traditional Chinese medicine for depression of young women |
| CN109223978A (en) * | 2017-07-10 | 2019-01-18 | 绫充匠 | A kind of therapeutic agent of post-natal depression |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1232698A (en) * | 1999-03-09 | 1999-10-27 | 李胤良 | Health beverage capable of tranquilizing through nourishing the heart |
| CN1242780C (en) * | 2002-05-31 | 2006-02-22 | 丁勤章 | Medicine compsn. for antagonizing poison-side effect caused by psychotropic drug |
| CN1298383C (en) * | 2005-04-13 | 2007-02-07 | 蒋希民 | Medicine for treating neurasthenia and its preparation method |
| CN100518781C (en) * | 2005-12-06 | 2009-07-29 | 成都中汇制药有限公司 | Xiegan-anshen oral-preparation preparing method and preparation thereof |
| CN101642540B (en) * | 2009-06-14 | 2011-11-02 | 李承平 | Chinese patent medicine for tranquilizing and allaying excitement |
| CN101757568B (en) * | 2010-04-19 | 2011-04-06 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating insomnia and preparation method thereof |
| CN101766754B (en) * | 2010-04-20 | 2011-04-27 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composite for treating coma and preparation method thereof |
| CN102423443B (en) * | 2011-12-27 | 2014-08-06 | 峨眉山天梁星制药有限公司 | Double-formula medicine used for treating insomnia, and preparation method thereof |
-
2012
- 2012-06-18 CN CN 201210199464 patent/CN102698094B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102698094A (en) | 2012-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100457176C (en) | Chinese medicinal preparation for curriculum of physical and fatigue reducing | |
| CN101559182B (en) | Traditional Chinese medicine for treating hyperpiesis and preparation method | |
| CN103893386A (en) | Health product for improving immunity and preparation method thereof | |
| CN102698094B (en) | Medicament for treating female depression | |
| CN106421579B (en) | A kind of Chinese medicine composition and preparation method thereof for treating fatigue | |
| CN102266052A (en) | Health care food with function of improving sleeping | |
| CN101549078A (en) | Pharmaceutical composition for treating intractable insomnia and preparation method thereof | |
| CN104225425A (en) | Chinese herbal preparation for enhancing immunity, improving sleep and preventing cardio-cerebrovascular disease, and preparation method thereof | |
| CN102068520B (en) | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN101954022B (en) | Chinese medicinal composition for treating lung cancer | |
| CN102698064B (en) | Medicament for treating climacteric syndrome | |
| CN102274423B (en) | Medicament for treating anxiety | |
| CN104491318A (en) | Traditional Chinese preparation used for treating asthma and preparation method of traditional Chinese preparation | |
| CN111358860A (en) | Traditional Chinese medicine composition for improving climacteric endocrine and preparation method and application thereof | |
| CN101019980B (en) | Health product for improving sleep quality | |
| CN104740148B (en) | A kind of Chinese medicine composition and preparation method thereof for treating post-stroke depression | |
| CN103705780A (en) | Medicament for treating intractable insomnia | |
| CN102641418B (en) | Medicament for treating migraine | |
| CN102552581B (en) | Medicament for treating insomnia | |
| CN102266482B (en) | Medicament for treating mania | |
| CN102727741B (en) | Medicament for treating anxiety disorder | |
| CN103041346A (en) | Decoction for treating dysmenorrhea | |
| CN103142977A (en) | Medicament for treating dysmenorrhea | |
| CN101708311B (en) | Chinese medicinal preparation for treating senile dementia | |
| CN114699474A (en) | Traditional Chinese medicine composition for treating ovarian reserve function reduction and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LIYANG SHANGHUANG HOSPITALS Free format text: FORMER OWNER: TIAN DONGMEI Effective date: 20131122 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272051 JINING, SHANDONG PROVINCE TO: 213314 CHANGZHOU, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131122 Address after: 213314, Huang Zhen Town, Liyang, Jiangsu, Changzhou Patentee after: Liyang Huang Zhen Town Health Center Address before: 272051 Shandong Province in Rencheng District of Jining City Li Ying Zhen Ji Dai Road No. 1 Jining city mental hospital Patentee before: Tian Dongmei |